Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Understanding when to start thinking about retirement can make a big difference. Explore key factors to help you plan effectively.
24,297 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A federal judge pressed the government over its bid to block Anthropic’s AI from top-secret systems. The hearing unde...
Oil hovers around $100 a barrel on March 25, 2026, as traders weigh demand growth against supply risks. The piece exp...
A Los Angeles jury finds Meta and YouTube liable on all charges in a landmark social media trial, signaling tighter o...
Ethereum sits just above $2,100 as on-chain data shows exchange reserves shrinking to levels not seen since 2016, wit...
Airbnb posts a solid Q4, prompting Truist to lift its target to $129 and move the stock to Hold. The shift signals a ...
With the CLARITY Act stalled in the Senate, XRP traders await a potential reset. A clearance could alter liquidity an...
An anonymous investor continues to buy the VanEck Uranium and Nuclear ETF every month, betting on nuclear power's lon...
As major indices retreat in March, traders question whether Trump losing grip market? influence is waning. Volatility...
Investors are flocking to renewable energy stocks as policy support and expanding clean-energy projects push the sect...
A sub-$1 pre-IPO company behind a headset-first work platform says 1.5m+ people spend their work week in headsets. It...
Ethereum stabilizes around the $1,800 support zone as traders eye a potential breakout above $2,400. Risk remains as ...